Endpoints for multimodal clinical trials in stage III non-small cell lung cancer (NSCLC): a consensus report

Lung Cancer. 1994 Nov:11 Suppl 3:S11-3. doi: 10.1016/0169-5002(94)91859-7.
No abstract available

Publication types

  • Consensus Development Conference
  • Review

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Humans
  • Lung Neoplasms / therapy*
  • Neoplasm Staging